SC refers 349 FDC medicines to Drug Advisory Board for relook Industry-The Economic Times — December 15, 2017 comments off A bench said that the 349 FDCs were banned pursuant to the Kokate Committee report, by notifications of the central government under Section 26A of the Drugs Act.
